Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010
Adult
Male
China
Adolescent
Science
Q
R
Transfusion Reaction
Blood Donors
Middle Aged
Communicable Diseases
3. Good health
Young Adult
03 medical and health sciences
Cross-Sectional Studies
0302 clinical medicine
Risk Factors
Odds Ratio
Prevalence
Medicine
Humans
Female
Child
Research Article
DOI:
10.1371/journal.pone.0094528
Publication Date:
2014-04-08T21:50:42Z
AUTHORS (4)
ABSTRACT
Background The prevalence of transfusion-transmissible infections (TTIs) in blood donations is important for evaluating safety and potential risks to the population. This study investigated TTIs among donors Western China suggested measures policy-makers. Methods screening results 66,311 between 2005 2010 from a central center were analyzed. hepatitis B virus (HBV), C (HCV), human immunodeficiency (HIV), syphilis expressed percentages entire group as well groups by demographic characteristics donation frequency, with differences analyzed using Fisher's exact or Chi-square test. Logistic regression was performed identify influencing factors detected results. Results 1,769 (2.67%, 95% CI 2.55–2.79%) donated had serological evidence infection at least one pathogen 44 (0.07%, 0.05–0.09%) showed multiple infections. seroprevalence HBV, HCV, HIV, 0.87% (95% 0.80–0.94%), 0.86% 0.79–0.93%), 0.31% 0.26–0.35%), 0.70% 0.64–0.76%) respectively. Trend analysis significant increase 2.44% 3.71% (χ2 = 100.72, p 0.00) over this 6-year period. positive rates varied along lines. top three risk test-positive identified age, education level frequency. older age lower educated linked higher TTIs. A decreasing associated an increasing frequency 562.78, 0.00). Conclusions Hepatitis found most, often conjunction syphilis. These primary threats safety. high positivity rate call further actions.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (50)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....